Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
61,113,534
-
Total 13F shares
-
66,744,591
-
Share change
-
+102,664
-
Total reported value
-
$2,459,763,309
-
Put/Call ratio
-
116%
-
Price per share
-
$36.86
-
Number of holders
-
215
-
Value change
-
+$20,095,641
-
Number of buys
-
92
-
Number of sells
-
95
Institutional Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q4 2023
As of 31 Dec 2023,
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,744,591 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Artisan Partners Limited Partnership, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.